pharmaphorum14h
Sanofi wins appeal in spat with NICE over Sarclisa
Sanofi has taken a small step towards potentially overturning a recent rejection by NICE for NHS use of Sarclisa as a ...
The Pharma Letter14h
UK looks again at Sarclisa for myeloma as demand grows
Sanofi (Euronext: SAN) has announced that the UK's health technology assessor will conduct a new review of its Sarclisa ...